Corporate
Comprehensive testing solutions to get your teams back to work safer
The COVID-19 pandemic has led to an increase in remote teams and employees for many of the corporate and business sectors. While the tools for remote working have improved many businesses are wondering how to return their employees to the office with safety and confidence in mind.
Fortunately, in the majority of cases social distancing, mask-wearing, and enhanced disinfection protocols can help to reduce the risk associated with contracting an infection from the workplace but, how do you prove your measures are effective and give your employees the peace of mind to return to the office?
The Eurofins SAFER@WORK™ program offers a complete range of solutions to help ensure you have the appropriate risk management protocols in place, ready-access to rapid clinical testing, and proactive monitoring strategies to limit the impact of COVID-19 in your facility.
Are you looking to return employees from quarantine back to the office?
Many businesses have had the opportunity to partake and enforce remote working in order to safeguard employees and the business itself however, business owners and employees are now anxious to return to work while balancing the need for safety.
Eurofins can work with you to design a testing protocol that evaluates which employees can safely return to work and when.
PCR Testing – Before employees return to the workplace it is recommended that they are tested for active COVID-19 infection. Eurofins provides results in <48 hours allowing you to make prompt and informed business decisions.
Antibody Testing – Eurofins provides IgG, IgM, and total antibody testing which can help determine if your employee has been exposed to COVID-19 and aid in the decision to return to work along with PCR testing.
How do you continually monitor the safety of your work environment for coronavirus?
Through the Eurofins COVID-19 Sentinel Early Detection™ program, you can now continuously monitor your environment and employees for the SARS-CoV-2 virus. Proactively detect the presence of COVID-19, pinpoint the source, implement controls, therefore; reducing the risk of a widespread outbreak.
Air Testing – Evaluate indoor spaces for the presence of SARS-CoV-2 virus in the air via air testing.
Surface Testing – To verify the effectiveness of your disinfection protocols as well as the opportunity to identify infection in the workplace from asymptomatic virus shedders.
Wastewater Testing – For office buildings and parks with consistently present populations, testing your facility's wastewater for SARS-CoV-2 can detect the presence of infection before a widespread outbreak occurs.
Worn Mask Testing – Another non-invasive monitoring solution includes testing worn masks from your employees. Testing of non-medical masks worn in the workplace for the COVID-19 virus that allows you to detect coronavirus likely to have originated from the employee wearing the mask. Please note, this is not a replacement for clinical testing.
Pooled PCR Testing - Pooled PCR clinical testing can be used to continuously and cost-effectively monitor pre-screened, low-risk groups that show a low prevalence of COVID-19 infection.
The Eurofins SAFER@WORK™ is the only long-term solution on the market today that provides comprehensive testing strategies and practical implementation approaches critical to reducing the impact of COVID-19.
Find your solution!
